1217975-31-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(S)-Benzyl 3-isopropylpiperazine-1-carboxylate is used as a research compound for its potential therapeutic properties in the development of new drugs. It is particularly valuable in the treatment of neurological disorders and mental health issues due to its unique chemical structure and properties.
Used in the Synthesis of Other Compounds:
As a carboxylate ester, (S)-benzyl 3-isopropylpiperazine-1-carboxylate can be used as a starting material or intermediate in the synthesis of other related compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Used in Chemical Reactions and Processes:
(S)-benzyl 3-isopropylpiperazine-1-carboxylate can be employed in various chemical reactions and processes to produce a range of products with different applications. Its versatility in chemical synthesis makes it a valuable asset in the field of pharmaceutical chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1217975-31-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,9,7 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1217975-31:
(9*1)+(8*2)+(7*1)+(6*7)+(5*9)+(4*7)+(3*5)+(2*3)+(1*1)=169
169 % 10 = 9
So 1217975-31-9 is a valid CAS Registry Number.
1217975-31-9Relevant academic research and scientific papers
PIPERAZINE DERIVATIVES AS LIVER X RECEPTOR MODULATORS
-
, (2016/04/04)
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver X receptor modulators, and which are useful in the treatment of diseases and disorders associated with the liver X receptor. Also provided are the compounds of Formula (I) and pharmaceutical compositions thereof for treating atherosclerosis, cardiovascular disease, Alzheimer's disease, dermatitis, dyslipidemia, cancer and other diseases or disorders.
CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS
-
, (2014/01/17)
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
